Back to search

Peptide record

TPDB18402

Antibacterial Antiviral Toxicity standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18402
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 15-aa standard natural multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
CKIPFEIMDLEKRHV
Physicochemical Analysis
C83H136N22O22S2
ANQGSTWY
EIK
1858.25
7.16
4
3
6
+0
6.76
-0.227
97.33
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
1
R
0
N
1
D
1
C
2
E
0
Q
0
G
1
H
2
I
1
L
2
K
1
M
1
F
1
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 1 C: 1 E: 2 Q: 0 G: 0 H: 1 I: 2 L: 1 K: 2 M: 1 F: 1 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
15
C83H136N22O22S2
1858.25
7.16
+0
6.76
-0.227
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin. | Antiviral Res | 2018
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.29709564]No toxic effect on HUVEC(Human umbilical vein endothelial cells) at concentrations up to 100 µM

Source & Reference

NA
DRAMP
Antiviral Res. 2018 Jul 155:20-27.